DE297436T1 - Behandlung von hyperhidrose, ichtyosis und faltenbildung. - Google Patents
Behandlung von hyperhidrose, ichtyosis und faltenbildung.Info
- Publication number
- DE297436T1 DE297436T1 DE198888110037T DE88110037T DE297436T1 DE 297436 T1 DE297436 T1 DE 297436T1 DE 198888110037 T DE198888110037 T DE 198888110037T DE 88110037 T DE88110037 T DE 88110037T DE 297436 T1 DE297436 T1 DE 297436T1
- Authority
- DE
- Germany
- Prior art keywords
- compound
- group
- azelaic acid
- ester
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000037373 wrinkle formation Effects 0.000 title 1
- 238000000034 method Methods 0.000 claims 19
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical class OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 12
- -1 oligosaccharide esters Chemical class 0.000 claims 8
- 150000002148 esters Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 6
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims 6
- 125000004432 carbon atom Chemical class C* 0.000 claims 5
- 150000001991 dicarboxylic acids Chemical class 0.000 claims 5
- 238000009472 formulation Methods 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 150000002763 monocarboxylic acids Chemical class 0.000 claims 5
- 208000008454 Hyperhidrosis Diseases 0.000 claims 4
- 206010040954 Skin wrinkling Diseases 0.000 claims 4
- 230000037315 hyperhidrosis Effects 0.000 claims 4
- 229920001542 oligosaccharide Polymers 0.000 claims 4
- 229920005862 polyol Polymers 0.000 claims 4
- 150000003077 polyols Chemical class 0.000 claims 4
- 206010066295 Keratosis pilaris Diseases 0.000 claims 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 1
- 206010051246 Photodermatosis Diseases 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 206010021198 ichthyosis Diseases 0.000 claims 1
- 230000008845 photoaging Effects 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (13)
1. Verfahren zur Behandlung von Haut, die unter Hyperhidrose, Ichthiose oder Faltenbildung leidet, wobei das Verfahren
das Auftragen einer therapeutisch wirksamen Menge
einer Verbindung auf den betroffenen Bereich umfaßt, die )
aus der aus Mono- und Dikarbonsäuren mit 4 bis 18 Kohlenstoffatomen,
Merkaptoderivaten derselben, Salzen derselben und Estern derselben besteht.
2. Verfahren nach Anspruch 1, bei dem die Verbindung aus der Gruppe ausgewählt wird, die aus Azelainsäure, Merkaptoderivaten
derselben, Salzen derselben und Estern derselben besteht.
3. Verfahren nach Anspruch 1, bei dem die Verbindung Azelainsäure ist.
4. Verfahren nach Anspruch 1, bei dem die Verbindung ein aus der Gruppe ausgewähltes Mitglied ist, welche aus Monoglyzerid
und Monosaccharoseestern von Azelainsäure besteht.
5. Verfahren zur Behandlung einer Haut, die an Hyperhidrose
leidet, wobei das Verfahren das Auftragen einer therapeutisch wirksamen Menge einer dermatologischen Formulierung
auf das betroffene Gebiet umfaßt, welche von 0,1 bis etwa 40 Gew.-% einer Verbindung enthält, die aus Mono- und
Dikarbonsäuren mit 4 bis 18 Kohlenstoffatomen,
Merkaptoderivaten derselben, Salzen derselben und Polyol- und Oligosaccharid-Estern derselben besteht.
Dikarbonsäuren mit 4 bis 18 Kohlenstoffatomen,
Merkaptoderivaten derselben, Salzen derselben und Polyol- und Oligosaccharid-Estern derselben besteht.
6. Verfahren nach Anspruch 5, bei dem die Verbindung ein aus der aus Azelainsäure, dem Monoglyzeridester und dem Monosaccharoseester
derselben bestehenden Gruppe ausgewählt
ist.
ist.
7. Verfahren für die Behandlung einer an Ichthiose leidenden
Haut, wobei das Verfahren das Auftragen einer therapeutisch wirksamen Menge einer dermatologischen Formulierung
T auf das betroffene Gebiet umfaßt, welche von etwa 0,1 bis
etwa 40 Gew.-% einer Verbindung enthält, die aus der aus Mono- und Dikarbonsäuren mit 4 bis 18 Kohlenstoffatomen,
Merkaptoderivaten derselben, Salzen derselben und Polyol- und Oligosaccharid-Estern derselben bestehenden Gruppe
ausgewählt, ist.
ausgewählt, ist.
8. Verfahren nach Anspruch 7, bei dem die Verbindung ein aus der aus Azelainsäure, dem Monoglyzeridester und dem Monosaccharoseester
derselben bestehenden Gruppe ausgewähltes Mitglied ist.
9. Verfahren zur Behandlung einer an Keratosis pilaris leidenden Haut, wobei das Verfahren das Auftragen einer
therapeutisch wirksamen Menge "einer dermatologischen Formulierung auf das betroffene Gebiet umfaßt, die Von 0,1
bis etwa 4 0 Gew.-% einer Verbindung enthält, welche aus
der aus Mono- und Dikarbonsäuren mit 7 bis 13 Kohlenstoffatomen, Merkaptoderivaten derselben, Salzen derselben und
therapeutisch wirksamen Menge "einer dermatologischen Formulierung auf das betroffene Gebiet umfaßt, die Von 0,1
bis etwa 4 0 Gew.-% einer Verbindung enthält, welche aus
der aus Mono- und Dikarbonsäuren mit 7 bis 13 Kohlenstoffatomen, Merkaptoderivaten derselben, Salzen derselben und
Polyol- und Oligosaccharid-Estern derselben bestehenden
Gruppe ausgewählt ist.
10. Verfahren nach Anspruch 9, bei dem die Verbindung ein
aus der aus Azelainsäure, dem Monoglyzeridester und dem Monosaccharoseester derselben ausgewähltes Mitglied ist.
11. Verfahren zur Behandlung einer an Faltenbildung infolge
von Eigen-Alterung oder Licht-Alterung leidenden Haut,
wobei das Verfahren das Auftragen einer therapeutisch wirksamen Menge einer dermatologischen Formulierung auf
das betroffene Gebiet umfaßt, welche von 0,1 bis etwa 4 0 Gew.-% einer Verbindung enthält, die aus der aus Mono-
und Dikarbonsäuren mit 7 bis 13 Kohlenstoffatomen, Merkaptoderivaten derselben, Salzen derselben und
Polyol- und Oligosaccharid-Estern derselben bestehenden Gruppe ausgewählt ist.
12. Verfahren nach Anspruch 11, bei dem die Verbindung ein aus der aus Azelainsäure, dem Monoglyzerid-Ester und dem
Monosaccharoseester derselben bestehenden Gruppe ausgewähltes Mitglied ist.
13. Verfahren zur Behandlung einer an Hyperhidrose, an Ichthiosis
vulgaris mit oder ohne Keratosis pilaris oder an Faltenbildung leidenden Haut, wobei das Verfahren das
Auftragen einer therapeutisch wirksamen Menge einer dermatologischen Formulierung auf die betroffene Fläche
umfaßt, welche von etwa 5 bis etwa 20 Gew.-% Azelainsäure enthält.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6907187A | 1987-07-02 | 1987-07-02 | |
US07/160,042 US4885282A (en) | 1987-07-02 | 1988-03-08 | Treatment of hyperhidrosis, ichthyosis and wrinkling |
Publications (1)
Publication Number | Publication Date |
---|---|
DE297436T1 true DE297436T1 (de) | 1989-08-03 |
Family
ID=26749652
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3853558T Expired - Fee Related DE3853558T2 (de) | 1987-07-02 | 1988-06-23 | Behandlung von Hyperhidrose und Ichtyosis. |
DE198888110037T Pending DE297436T1 (de) | 1987-07-02 | 1988-06-23 | Behandlung von hyperhidrose, ichtyosis und faltenbildung. |
DE3855489T Expired - Fee Related DE3855489T2 (de) | 1987-07-02 | 1988-06-23 | Behandlung von Hautfalten |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3853558T Expired - Fee Related DE3853558T2 (de) | 1987-07-02 | 1988-06-23 | Behandlung von Hyperhidrose und Ichtyosis. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3855489T Expired - Fee Related DE3855489T2 (de) | 1987-07-02 | 1988-06-23 | Behandlung von Hautfalten |
Country Status (4)
Country | Link |
---|---|
US (1) | US4885282A (de) |
EP (2) | EP0297436B1 (de) |
JP (3) | JP2608762B2 (de) |
DE (3) | DE3853558T2 (de) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4885282A (en) * | 1987-07-02 | 1989-12-05 | Thornfeldt Carl R | Treatment of hyperhidrosis, ichthyosis and wrinkling |
DE3811081A1 (de) * | 1988-03-30 | 1989-10-12 | Schering Ag | Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut |
IT1232161B (it) * | 1989-07-31 | 1992-01-25 | Sigma Tau Ind Farmaceuti | Uso dell'acido sebacico e di suoi derivati nell'alimentazione enterale e parentaerale e composizioni farmaceutiche contenenti tali composti |
JP2558188B2 (ja) * | 1991-06-10 | 1996-11-27 | 花王株式会社 | 入浴剤組成物 |
GB9213472D0 (en) * | 1992-06-25 | 1992-08-12 | Unilever Plc | Cosmetic composition |
GB9220670D0 (en) * | 1992-09-30 | 1992-11-11 | Unilever Plc | Cosmetic composition |
DE4434775A1 (de) * | 1994-09-29 | 1996-04-04 | Beiersdorf Ag | Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen |
DE4435290A1 (de) * | 1994-10-01 | 1996-04-04 | Beiersdorf Ag | Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen |
UY24246A1 (es) * | 1995-06-06 | 1996-06-14 | Neutrogena Corp | Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado |
US5609587A (en) * | 1995-08-03 | 1997-03-11 | The Procter & Gamble Company | Diaper having a lotioned topsheet comprising a liquid polyol polyester emollient and an immobilizing agent |
US5624676A (en) * | 1995-08-03 | 1997-04-29 | The Procter & Gamble Company | Lotioned tissue paper containing an emollient and a polyol polyester immobilizing agent |
US5705164A (en) * | 1995-08-03 | 1998-01-06 | The Procter & Gamble Company | Lotioned tissue paper containing a liquid polyol polyester emollient and an immobilizing agent |
US5607760A (en) * | 1995-08-03 | 1997-03-04 | The Procter & Gamble Company | Disposable absorbent article having a lotioned topsheet containing an emollient and a polyol polyester immobilizing agent |
JP3854326B2 (ja) * | 1995-10-27 | 2006-12-06 | 株式会社ノエビア | コラゲナーゼ阻害剤 |
US5621008A (en) * | 1995-10-27 | 1997-04-15 | Avon Products, Inc. | N-acyl-ethylene-triacetic acids |
DE19543696A1 (de) * | 1995-11-23 | 1997-05-28 | Beiersdorf Ag | Gegen Bakterien, Mycota und Viren wirksame Wirkstoffkombinationen auf der Basis von Partialglyceriden und dialkylsubstituierte Essigsäuren |
JP3583239B2 (ja) * | 1996-01-25 | 2004-11-04 | 花王株式会社 | 皮膚外用剤 |
US5932229A (en) * | 1996-04-25 | 1999-08-03 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5834513A (en) * | 1996-04-25 | 1998-11-10 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5847003A (en) * | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
FR2755369B1 (fr) * | 1996-11-04 | 1998-12-04 | Oreal | Composition moussante pour le nettoyage de la peau sous la forme d'un gel transparent |
FR2755368B1 (fr) * | 1996-11-04 | 1999-03-19 | Oreal | Composition rincable pour le soin de la peau |
FR2755366B1 (fr) * | 1996-11-04 | 1998-12-04 | Oreal | Composition rincable pour le soin de la peau |
FR2755370B1 (fr) * | 1996-11-04 | 1998-12-04 | Oreal | Composition nettoyante sous la forme d'un gel transparent rincable |
KR20000053244A (ko) | 1996-11-12 | 2000-08-25 | 도브 타마킨 | 피부질환의 치료방법 |
TWI234467B (en) * | 1997-06-04 | 2005-06-21 | Univ Michigan | Composition for inhibiting photoaging of skin |
US20050058709A1 (en) * | 1997-06-04 | 2005-03-17 | Fisher Gary J. | Methods for inhibiting photoaging of human skin using orally-administered agent |
US6780403B1 (en) * | 1999-07-26 | 2004-08-24 | Kao Corporation | Deodorants |
WO2001008681A1 (en) * | 1999-08-02 | 2001-02-08 | First Horizon Pharmaceutical Corporation | Methods of administration of glycopyrrolate compositions |
US6447789B1 (en) | 1999-10-13 | 2002-09-10 | Terrie E. Banks | Facial cleanser and method of treating skin conditions |
US6734210B2 (en) | 2000-02-24 | 2004-05-11 | Rolland F. Hebert | Therapeutically improved salts of azelaic acid |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
DE10039783A1 (de) * | 2000-08-16 | 2002-02-28 | Cognis Deutschland Gmbh | Kosmetische Zubereitungen |
US7226605B2 (en) * | 2001-07-27 | 2007-06-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Botulinum toxin in the treatment or prevention of acne |
US20030224027A1 (en) * | 2002-05-29 | 2003-12-04 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic compositions with ammonium malonates |
US20030224023A1 (en) * | 2002-05-29 | 2003-12-04 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic compositions with hydroxy amine salts of malonic acid |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
ES2532906T5 (es) | 2002-10-25 | 2022-03-23 | Foamix Pharmaceuticals Ltd | Espuma cosmética y farmacéutica |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20040185073A1 (en) * | 2003-03-17 | 2004-09-23 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic compositions containing salts of malonic acid |
US20040185074A1 (en) * | 2003-03-17 | 2004-09-23 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Odor control in amine salt containing cosmetic compositions |
US20040202689A1 (en) * | 2003-03-17 | 2004-10-14 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Terpenoid fragrance components stabilized with malonic acid salts |
US20040185015A1 (en) * | 2003-03-17 | 2004-09-23 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Sunscreen cosmetic compositions storage stabilized with malonate salts |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US20040259744A1 (en) * | 2003-12-19 | 2004-12-23 | Meidong Yang | Skin and hair cleansers containing sulfur |
ATE520390T1 (de) | 2004-12-27 | 2011-09-15 | Beiersdorf Ag | Glycopyrrolat in kosmetischen zubereitungen |
JP3955868B2 (ja) * | 2004-12-27 | 2007-08-08 | 株式会社キングジム | 書類等の綴じ具 |
DE102005029387B4 (de) * | 2005-06-23 | 2018-12-27 | Beiersdorf Ag | Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyglyceryl(3)-Methylglucosedistearat |
BRPI0612428A2 (pt) | 2005-05-09 | 2010-11-09 | Foamix Ltd | composição farmacêutica higroscópica, veìculo farmacêutico espumoso e composição farmacêutica espumosa |
US8236333B2 (en) | 2005-10-19 | 2012-08-07 | Unirem, Inc. | Active agent delivery and/or odor retentive composition and methods of use thereof |
WO2007140791A1 (en) * | 2006-06-08 | 2007-12-13 | Astion Pharma A/S | Treatment of cutaneous neurogenic inflammation |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US20080260823A1 (en) * | 2007-04-20 | 2008-10-23 | Sciele Pharma, Inc. | Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009090558A2 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US8729108B2 (en) * | 2008-06-17 | 2014-05-20 | Christopher J Dannaker | Waterborne topical compositions for the delivery of active ingredients such as azelaic acid |
WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
BR112012007473A2 (pt) | 2009-10-02 | 2019-05-07 | Foamix Ltd | composições tópicas de tetraciclina e respectivo método de uso |
AU2014223172B2 (en) | 2013-02-28 | 2016-09-08 | Journey Medical Corporation | Glycopyrrolate salts |
US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
AU2014297993A1 (en) | 2013-07-30 | 2016-02-04 | Glaxosmithkline Intellectual Property Development Limited | Topical compositions for treatment of excessive sweating and methods of use thereof |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS522979B2 (de) * | 1972-09-29 | 1977-01-25 | ||
US4294852A (en) * | 1973-11-01 | 1981-10-13 | Johnson & Johnson | Skin treating compositions |
DE2608221B1 (de) * | 1976-02-28 | 1977-07-21 | Beiersdorf Ag | Kosmetisches mittel zur glaettung der haut |
US4386104A (en) * | 1977-04-19 | 1983-05-31 | Nazzaro Porro Marcella | Process for the treatment of acne |
IT1114950B (it) * | 1977-12-30 | 1986-02-03 | Porro Marcella | Composizioni per il trattamento e la terapia di acne |
DK159967C (da) * | 1977-12-22 | 1991-06-03 | Hoffmann La Roche | Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater |
JPS56131512A (en) * | 1980-03-19 | 1981-10-15 | Kanebo Keshohin Kk | Scrubbing skin cleaner |
FR2492815A1 (fr) * | 1980-10-23 | 1982-04-30 | Sori Soc Rech Ind | Nouveau derive d'acide cinnamoyl-cinnamique, son procede de preparation et son application en therapeutique |
JPS58103319A (ja) * | 1981-12-14 | 1983-06-20 | Pola Chem Ind Inc | 皮膚塗布用組成物 |
JPS59501986A (ja) * | 1982-11-04 | 1984-11-29 | レツドケン ラボラトリ−ズ インコ−ポレイテイツド | 化粧品製剤 |
GB8600822D0 (en) * | 1986-01-15 | 1986-02-19 | Unilever Plc | Treatment of skin disorders |
US4713394A (en) * | 1986-01-17 | 1987-12-15 | Thornfeldt Carl R | Treatment of nonacne inflammatory and infectious dermatoses and hair loss |
DE3623862A1 (de) * | 1986-07-11 | 1988-01-21 | Schering Ag | Verwendung von dicarbonsaeuren mit 7 - 13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur topischen behandlung von rosazea |
ZA879063B (en) * | 1986-12-22 | 1989-04-26 | Hoffmann La Roche | Use of 13-cis retinoic acid |
AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
US4885282A (en) * | 1987-07-02 | 1989-12-05 | Thornfeldt Carl R | Treatment of hyperhidrosis, ichthyosis and wrinkling |
JPH0745401A (ja) * | 1993-07-30 | 1995-02-14 | Matsushita Electric Ind Co Ltd | 正特性サーミスタの製造方法 |
-
1988
- 1988-03-08 US US07/160,042 patent/US4885282A/en not_active Expired - Lifetime
- 1988-06-23 DE DE3853558T patent/DE3853558T2/de not_active Expired - Fee Related
- 1988-06-23 DE DE198888110037T patent/DE297436T1/de active Pending
- 1988-06-23 EP EP88110037A patent/EP0297436B1/de not_active Expired - Lifetime
- 1988-06-23 DE DE3855489T patent/DE3855489T2/de not_active Expired - Fee Related
- 1988-06-23 EP EP93118766A patent/EP0588379B1/de not_active Expired - Lifetime
- 1988-06-30 JP JP63164788A patent/JP2608762B2/ja not_active Expired - Lifetime
-
1994
- 1994-02-25 JP JP6028599A patent/JPH085785B2/ja not_active Expired - Lifetime
- 1994-02-25 JP JP6028600A patent/JP2538516B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH085785B2 (ja) | 1996-01-24 |
JPS6429308A (en) | 1989-01-31 |
EP0588379A3 (en) | 1994-06-01 |
EP0297436B1 (de) | 1995-04-12 |
JPH06298643A (ja) | 1994-10-25 |
EP0297436A2 (de) | 1989-01-04 |
JP2608762B2 (ja) | 1997-05-14 |
DE3855489D1 (de) | 1996-09-26 |
EP0297436A3 (de) | 1991-05-15 |
DE3853558T2 (de) | 1995-08-24 |
JP2538516B2 (ja) | 1996-09-25 |
EP0588379A2 (de) | 1994-03-23 |
US4885282A (en) | 1989-12-05 |
DE3853558D1 (de) | 1995-05-18 |
EP0588379B1 (de) | 1996-08-21 |
DE3855489T2 (de) | 1996-12-19 |
JPH06321779A (ja) | 1994-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE297436T1 (de) | Behandlung von hyperhidrose, ichtyosis und faltenbildung. | |
KR100904573B1 (ko) | 피부 관리 조성물 | |
DE229654T1 (de) | Behandlung von nicht-akne-entzuendlichen und -infektioesen hautkrankheiten und haarausfall. | |
DE2719533C2 (de) | ||
EP0336880A3 (de) | Verwendung von topisch applizierbaren Präparaten zur Behandlung der Altershaut | |
DE1912352C3 (de) | Pyridin-N-oxyd-Derivale und Verfahren zu ihrer Herstellung | |
CA2144312A1 (en) | Unsaturated aliphatic dicarboxylic acids | |
DE133795T1 (de) | Gaba-ester und gaba-analoge ester. | |
DE2300594C2 (de) | Hautbehandlungsmittel | |
DE69633009T2 (de) | Nicotinsäureester und diese enthaltende pharmazeutischen zusammensetzungen | |
DE69632237T2 (de) | Kosmetische Zusammensetzungen enthaltend Tricholinecitrat | |
DE69936635T2 (de) | Verwendundung von Rhamnolipiden als Kosmetika | |
EP0079913B1 (de) | Arencarbonsäure-derivate als antiseborrhoische zusätze für kosmetische mittel | |
DE60316221T2 (de) | Glucosederivat von Vitamin F, Zusammensetzungen, die es enthalten, Verwendungen und Herstellungsverfahren | |
DE100651T1 (de) | Dialkylmalonate als organische hilfsmittel fuer sonnenschutzmittel. | |
EP0286774A1 (de) | Mittel und Verfahren zur dauerhaften Haarverformung | |
DE1952057A1 (de) | Mittel zur Behandlung der menschlichen Haut | |
DE69802908T2 (de) | Salicylsäure - sphingoidbase derivate und ihre verwendung | |
US4143160A (en) | Process for moisturing the skin | |
DE69101651T2 (de) | Pharmazeutische Zusammensetzung, welche eine depigmentierende und eine der Photoalterung entgegenwirkende Aktivität hat. | |
DE3500972A1 (de) | Sebosuppressive kosmetische mittel, enthaltend alkoxy- oder alkylbenzyloxy-benzoesaeuren oder deren salze | |
DE1286692B (de) | Kosmetische, pharmazeutische oder schuetzende Mittel zur Aufbringung auf die Haut sowie Salbengrundlagen | |
DE3049123C2 (de) | Fettsaeureester von 4-isopropyltropolon und hautverschoenerndes, kosmetisches mittel | |
DE3204235C2 (de) | ||
DE1617705C3 (de) | Kosmetisches Mittel fur die Haar behandlung |